Elixirr International plc (LON:ELIX - Get Free Report) insider Simon Retter bought 1,619 shares of the stock in a transaction dated Wednesday, March 18th. The shares were acquired at an average price of GBX 636 per share, with a total value of £10,296.84.
Simon Retter also recently made the following trade(s):
- On Thursday, February 26th, Simon Retter bought 382 shares of Elixirr International stock. The stock was bought at an average cost of GBX 680 per share, with a total value of £2,597.60.
- On Thursday, February 26th, Simon Retter purchased 883 shares of Elixirr International stock. The shares were purchased at an average cost of GBX 680 per share, for a total transaction of £6,004.40.
- On Tuesday, February 24th, Simon Retter bought 1,476 shares of Elixirr International stock. The shares were acquired at an average cost of GBX 677 per share, for a total transaction of £9,992.52.
Elixirr International Stock Performance
ELIX traded down GBX 25.62 on Thursday, hitting GBX 604.38. 26,637 shares of the company's stock were exchanged, compared to its average volume of 86,596. The company has a current ratio of 0.82, a quick ratio of 1.29 and a debt-to-equity ratio of 11.78. The stock has a fifty day moving average of GBX 741.64 and a two-hundred day moving average of GBX 793.11. Elixirr International plc has a twelve month low of GBX 560 and a twelve month high of GBX 905.63. The firm has a market cap of £294.57 million, a PE ratio of 16.86 and a beta of 0.55.
About Elixirr International
(
Get Free Report)
Elixirr is a global consulting firm with a bold ambition: to become the best consulting firm in the world.
Founded in 2009 to challenge a declining industry standard, we've grown from a single vision into a powerhouse of entrepreneurial talent. We partner with businesses around the world to deliver transformational results, from boardroom strategy through to execution, powered by the technology of tomorrow. We do this in a way that's anything but traditional – helping our clients change the game in their industries, just as we are changing the game in ours.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Elixirr International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elixirr International wasn't on the list.
While Elixirr International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.